Halozyme Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
KELLEY KENNETH J director
Common Stock 12,500 $10.43 $130,425
Sale
KELLEY KENNETH J director
Common Stock 25,000 $10.37 $259,175
Option
KELLEY KENNETH J director
Option to Purchase Common Stock 37,500 $4.1 $153,750
Option
KELLEY KENNETH J director
Common Stock 25,000 $4.1 $102,500
Option
KELLEY KENNETH J director
Common Stock 25,000 $4.1 $102,500
Sale
KELLEY KENNETH J director
Common Stock 25,000 $8.93 $223,225
Option
KELLEY KENNETH J director
Option to Purchase Common Stock 25,000 $4.1 $102,500
Sale
PATTON JOHN STUART director
Common Stock 25,000 $9.17 $229,300
Option
KELLEY KENNETH J director
Option to Purchase Common Stock 25,000 $4.1 $102,500
Sale
KELLEY KENNETH J director
Common Stock 25,000 $9.07 $226,725
Option
KELLEY KENNETH J director
Common Stock 25,000 $4.1 $102,500
Sale
PATTON JOHN STUART director
Common Stock 25,000 $8.66 $216,375
Option
KELLEY KENNETH J director
Common Stock 25,000 $4.1 $102,500
Sale
KELLEY KENNETH J director
Common Stock 25,000 $8.49 $212,275
Option
KELLEY KENNETH J director
Option to Purchase Common Stock 25,000 $4.1 $102,500
Sale
PATTON JOHN STUART director
Common Stock 25,000 $8.36 $208,900
Option
KELLEY KENNETH J director
Option to Purchase Common Stock 25,000 $4.1 $102,500
Sale
KELLEY KENNETH J director
Common Stock 25,000 $8.06 $201,400
Option
KELLEY KENNETH J director
Common Stock 25,000 $4.1 $102,500
Sale
PATTON JOHN STUART director
Common Stock 50,000 $8.41 $420,300
Sale
KELLEY KENNETH J director
Common Stock 8,738 $8.35 $72,927
Sale
KELLEY KENNETH J director
Common Stock 16,262 $8.41 $136,747
Option
KELLEY KENNETH J director
Common Stock 25,000 $2.05 $51,250
Option
KELLEY KENNETH J director
Option to Purchase Common Stock 25,000 $2.05 $51,250
Option
THORNTON STEVEN T director
Common Stock 10,000 $1.75 $17,500
Sale
YOCUM RICHARD C officer: VP-Clinical Development
Common Stock 29,858 $8.52 $254,450
Option
THORNTON STEVEN T director
Option to Purchase Common Stock 10,000 $1.75 $17,500
Sale
THORNTON STEVEN T director
Common Stock 10,000 $8.56 $85,590
Option
YOCUM RICHARD C officer: VP-Clinical Development
Option to Purchase Common Stock 95,833 $1.87 $179,208
Sale
PATTON JOHN STUART director
Common Stock 25,000 $8.65 $216,200
Option
YOCUM RICHARD C officer: VP-Clinical Development
Common Stock 95,833 $1.87 $179,208
Purchase
LITTLE ROBERT J officer: VP, Chief Commercial O..
Common Stock 800 $8.62 $6,896
Purchase
LITTLE ROBERT J officer: VP, Chief Commercial O..
Common Stock 3,200 $8.65 $27,680
Sale
KELLEY KENNETH J director
Common Stock 25,000 $8.74 $218,500
Option
KELLEY KENNETH J director
Common Stock 25,000 $2.05 $51,250
Option
KELLEY KENNETH J director
Option to Purchase Common Stock 25,000 $2.05 $51,250
Sale
ENGLER ROBERT director
Common Stock 25,000 $8.04 $201,075
Sale
PATTON JOHN STUART director
Common Stock 8,600 $8 $68,800
Option
KELLEY KENNETH J director
Common Stock 25,000 $2.05 $51,250
Sale
PATTON JOHN STUART director
Common Stock 16,400 $8.02 $131,528
Purchase
KIRK RANDAL J 10 percent owner
Common Stock 30,200 $7.91 $238,882
Sale
KELLEY KENNETH J director
Common Stock 25,000 $7.94 $198,425
Option
KELLEY KENNETH J director
Option to Purchase Common Stock 25,000 $2.05 $51,250
Purchase
KIRK RANDAL J 10 percent owner
Common Stock 46,080 $7.93 $365,414
Purchase
KIRK RANDAL J 10 percent owner
Common Stock 80,000 $6.16 $492,800
Purchase
KIRK RANDAL J 10 percent owner
Common Stock 336,200 $5.55 $1,865,910
Purchase
KIRK RANDAL J 10 percent owner
Common Stock 53,500 $2.84 $151,940
Purchase
KIRK RANDAL J 10 percent owner
Common Stock 11,500 $2.86 $32,890
Purchase
KIRK RANDAL J 10 percent owner
Common Stock 102,500 $2.5 $256,250
Purchase
KIRK RANDAL J 10 percent owner
Common Stock 20,000 $2.5 $50,000

Showing 800 to 850 of 885 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.